A Real-World Study of JT001 for COVID-19
- Conditions
- COVID-19
- Registration Number
- NCT06142201
- Lead Sponsor
- Shanghai Vinnerna Biosciences Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 7656
Inclusion Criteria:<br><br> 1. Age =18 years old.<br><br> 2. The novel coronavirus infection (COVID-19) meets at least one of the following five<br> criteria:<br><br> 1) Diagnosis of novel coronavirus infection; 2) Diagnosed with novel coronavirus<br> pneumonia; 3) The novel coronavirus nucleic acid test is positive; 4) Test positive<br> for novel coronavirus antigen; 5) Culture positive for novel coronavirus.<br><br> 3. Patients who have not developed severe COVID-19 or died within 28 days of COVID-19<br> diagnosis, or who have developed severe COVID-19 or died within 28 days of COVID-19<br> diagnosis, were treated with deuterimodivir hydrobromide tablets or were not treated<br> with anti-novel coronavirus before disease progression.<br><br>Exclusion Criteria:<br><br>· Patients who have not developed severe COVID-19 or died within 28 days of COVID-19<br>diagnosis, or those who have developed severe COVID-19 or died within 28 days of COVID-19<br>diagnosis, received the following anti-novel coronavirus treatments before disease<br>progression, including: Nematavir tablet/Ritonavir tablet, Azvudine tablet, Monoravir<br>capsule, Zenotavir tablet/Ritonavir tablet, Leritvir tablet, Ambavirzumab/Romisivir<br>injection, human immunoglobulin for COVID-19 or convalescent plasma for COVID-19<br>survivors.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of COVID-19 disease progression (severe COVID-19 or all-cause death) by day 28
- Secondary Outcome Measures
Name Time Method Incidence of the following COVID-19 disease progression events by day 28;Incidence of severe Covid-19-related events up to day 28;The incidence of all aes and abnormal laboratory changes on day 28, etc